For Immediate Release
March 16, 2009

Media Contact:
Monica Kozak
888.275.6202, Ext.730
Direct: 203.545.1055
Monica@horizonmarketing.com

Stem Cell Industry Expert Mercedes Walton Discusses President Obama’s Stem Cell Executive Order

—Mercedes Walton, Chairman and CEO of C’elle and Cryo-Cell International®,
Welcomes President Obama’s Stem Cell Decision  —

Oldsmar, FL—As the CEO of C’elle and Cryo-Cell International, the nation’s most established cord blood bank, Mercedes Walton has been an active participant in the stem cell and cord blood industry for several years. She has seen first-hand the changes that have taken place over the past decade and is pleased by President Obama’s Executive Order, signed March 9, 2009, which reverses a 2001 Executive Order banning federal funds for embryonic stem cell research.  

 “We were excited to hear the news that President Obama reversed the existing legislation regarding the use of federal funds for stem cell research.  While we recognize that not everyone agrees on how best to proceed with certain forms of stem cell research, we can certainly find common ground in agreeing that we are united in our desire to uncover new and better ways to improve the quality of our lives,” said Walton.   

The Executive Order is lauded as affirming  the American government’s belief in scientific progress and offers hope of better treatments and cures to millions of Americans suffering from debilitating diseases such as leukemia, heart disease, diabetes and Parkinson’s.  The Executive Order reflects the opinions of a majority of Americans who support increased federal funding for stem cell research due to the great lifesaving potential it holds.

Walton went on to say, “The responsible and productive use of stem cell research is of the utmost importance to all of us at C’elle and Cryo-Cell.”  A pioneer in the stem cell arena, Walton has successfully established a state-of-the-art Good Manufacturing Practice/Good Tissue Practice (cGMP/cGTP) laboratory processing facility well ahead of emerging regulation and competition and launched several innovative marketing initiatives and strategic alliances targeting both the consumer and professional sectors.

For more information, or to schedule an interview with Mercedes Walton, please contact Monica Kozak at (203) 545-1055; monica@horizonmarketing.com.

About Cryo-Cell International, Inc. (OTCBB: CCEL.OB)

Based in Oldsmar, Florida, with over 160,000 clients worldwide, Cryo-Cell is one of the largest and most established family cord blood banks. ISO 9001:2000 certified and accredited by the AABB, Cryo-Cell operates in a state-of-the-art Good Manufacturing Practice and Good Tissue Practice (cGMP/cGTP)-compliant facility. Cryo-Cell is a publicly traded company. OTC Bulletin Board Symbol: CCEL. For more information, please call 1-800-STOR-CELL (1-800-786-7235) or visit www.cryo-cell.com.

About C’elle

Based in Oldsmar, Florida, C’elle is the first available service that enables women to collect and cryopreserve stem cells collected from their menstrual flow. C’elle is a proprietary service of Cryo-Cell International, Inc., one of the largest and most established family cord blood banksin the nation. C'elle was developed by researchers at Cryo-Cell following the company's discovery of unique and highly prolific stem cells in menstrual fluid. C'elle has the potential to benefit millions of women worldwide, since stem cells found in menstrual blood may potentially be utilized in a broad range of future regenerative therapies to possibly treat a number of debilitating conditions such as heart disease, stroke and diabetes. C'elle stem cells may also have potential to be used in cosmeceutical applications such as anti-aging and sports medicine. For more information on C’elle, please call 1-877-892-3553 or visit www.celle.com.